Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

What Are Best Practices in Literature Monitoring for Top-performing Pharma Companies?

Posted on June 14th, 2017 by in Pharmacovigilance

The health and safety of patients is of utmost concern to pharmaceutical companies, and strict regulatory requirements ensure that safety standards remain high. But pharmacovigilance becomes an ever more difficult and overwhelming practice Continue reading “What Are Best Practices in Literature Monitoring for Top-performing Pharma Companies?” »

Self-Promoting Scientists: Building Trust with the Public

Posted on May 31st, 2017 by in Pharma R&D

 

Scientist

At Sequencing the Genome: Examining Modern Medicine, an event recently held in New York City and sponsored by The Atlantic, a series of panelists spoke on many aspects of genomics ranging from its progress in treating disease to its potential for stopping epidemics Continue reading “Self-Promoting Scientists: Building Trust with the Public” »

Inside the Incubators of Innovation

Posted on February 15th, 2017 by in Pharma R&D

2017 is well under way, and Arctic Pharma has big plans for the year. For one thing, we will be focused on submitting our provisional patents. We will also be working on performing toxicology studies on our best compounds. Continue reading “Inside the Incubators of Innovation” »

Medicine Non-adherence: Time for a Personalized Healthcare Approach?

Posted on December 19th, 2016 by in Pharma R&D

It was interesting to note the article from Beth Snyder Bulik (1) that patient non-adherence to taking their prescribed medicines not only has a potential impact on their health and wellbeing, it also impacts the companies’ and healthcare providers’ bottom lines. Continue reading “Medicine Non-adherence: Time for a Personalized Healthcare Approach?” »

  1. 1
  2. 2